# OnCo record embark (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/embark/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "embark", "NCT02319837" ;
  schema:name "EMBARK"@en ;
  schema:description "Showed that treating a fast-rising PSA after surgery or radiation with enzalutamide delays spread."@en ;
  schema:url <https://onco.cc/trials/embark/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02319837>, <https://www.nice.org.uk/guidance/ta580> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2014-12-17" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-bcr/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/enzalutamide/> ;
  onco:companies <https://onco.cc/companies/astellas/> ;
  onco:terms <https://onco.cc/terms/biochemical-recurrence/>, <https://onco.cc/terms/prostate-uk-drug-approvals/>, <https://onco.cc/terms/metastasis-free-survival/>, <https://onco.cc/terms/psa-doubling-time/> ;
  onco:trials <https://onco.cc/trials/radicals-hd/>, <https://onco.cc/trials/getug-afu-16/>, <https://onco.cc/trials/stomp-oligorecurrence/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-embark-nejm-2023/> .
